2025 Europe Antibodies Market Revenue Opportunities Report
Description
The 2025 Europe Antibodies Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antibodies Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European antibodies market include Roche, Merck KGaA, Thermo Fisher Scientific Inc., and Agilent Technologies, Inc. Roche, headquartered in Switzerland, leads the monoclonal antibodies sector with strong oncology and immunology portfolios, showing significant growth in cancer-targeted therapies. Merck KGaA, based in Germany, also holds a significant market share, actively expanding through distribution partnerships and product innovation in both diagnostic and therapeutic antibody applications. Thermo Fisher Scientific dominates the diagnostic antibodies segment in Europe with an extensive product portfolio focused on high-specificity antibodies, driving innovation and regional presence. Agilent Technologies holds the second-largest market share and advances the market through new product introductions and acquisitions to broaden regional reach.
Additionally, other notable players like Argenx and Genmab are pioneering in immunology and bispecific antibody therapies, contributing to antibody innovation in autoimmune and oncological diseases. These companies leverage advanced antibody engineering and strategic collaborations to develop targeted therapies, including bispecific antibodies that engage multiple disease pathways, reinforcing Europe’s leadership in the global antibodies market. Their activities complement the established giants by focusing on next-generation treatments and expanding the applications of antibody therapies in complex diseases.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antibodies Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European antibodies market include Roche, Merck KGaA, Thermo Fisher Scientific Inc., and Agilent Technologies, Inc. Roche, headquartered in Switzerland, leads the monoclonal antibodies sector with strong oncology and immunology portfolios, showing significant growth in cancer-targeted therapies. Merck KGaA, based in Germany, also holds a significant market share, actively expanding through distribution partnerships and product innovation in both diagnostic and therapeutic antibody applications. Thermo Fisher Scientific dominates the diagnostic antibodies segment in Europe with an extensive product portfolio focused on high-specificity antibodies, driving innovation and regional presence. Agilent Technologies holds the second-largest market share and advances the market through new product introductions and acquisitions to broaden regional reach.
Additionally, other notable players like Argenx and Genmab are pioneering in immunology and bispecific antibody therapies, contributing to antibody innovation in autoimmune and oncological diseases. These companies leverage advanced antibody engineering and strategic collaborations to develop targeted therapies, including bispecific antibodies that engage multiple disease pathways, reinforcing Europe’s leadership in the global antibodies market. Their activities complement the established giants by focusing on next-generation treatments and expanding the applications of antibody therapies in complex diseases.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
